Denmark's Leo Pharma is pushing its IPO plans past 2026 on market volatility

Summary
CEO Christophe Bourdon said Leo Pharma's owners see market conditions as unsuitable and declined to give a new timeline
Description from Quartz.
Who is covering this
-
Denmark's Leo Pharma is pushing its IPO plans past 2026 on market volatility
CEO Christophe Bourdon said Leo Pharma's owners see market conditions as unsuitable and declined to give a new timeline
Comments
Comments need JavaScript.